Adlai Nortye Ltd.
NASDAQ:ANLBiotechnology
Healthcare
$8.74 -1.07%
-$0.11 today
- Market cap
- $463.92M
- Beta
- 0.99
- P/E (TTM)
- -3.0
- EPS (TTM)
- -$3.33
52W Low $0.88High $17.25
Volume 0.45M
Average 0.35M
Cash Flow
Check whether earnings turn into cash.
Operating Cash Flow
-$33.54M
FY 2025 · Annual
Investing Cash Flow
-$15.62M
FY 2025 · Annual
Financing Cash Flow
-$3.82M
FY 2025 · Annual
Cash Flow Statement
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (56.68M) | (58.79M) | (104.87M) | (51.87M) | (35.62M) |
| Depreciation & Amortization | 1.83M | 2.04M | 2.22M | 1.87M | 1.42M |
| Deferred Income Tax | (67K) | (1.04M) | 0 | 0 | 0 |
| Stock-Based Compensation | 3.39M | 6.08M | 4.33M | 2.45M | 0 |
| Change in Working Capital | 250K | 15.25M | 6.12M | (5.54M) | (2.29M) |
| Accounts Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 600K | 10.12M | 1.25M | (4.2M) | 2.5M |
| Other Working Capital | (350K) | 5.13M | 4.87M | (1.34M) | (4.79M) |
| Other Non-Cash Items | 48.25M | (6.76M) | 35.54M | 1.27M | 2.96M |
| Operating Cash Flow | (3.03M) | (43.22M) | (56.65M) | (51.82M) | (33.54M) |
| Capital Expenditures | (1.12M) | (1.27M) | (200K) | (170K) | (187.49K) |
| Acquisitions (Net) | (102K) | (2K) | 0 | (4.21M) | 0 |
| Purchases of Investments | (81.23M) | (58.98M) | (31.83M) | (60.55M) | (20.49M) |
| Sales of Investments | 27.47M | 88.06M | 21.02M | 92.26M | 5.05M |
| Other Investing Activities | 134K | 569K | 53.6K | 734K | 0 |
| Investing Cash Flow | (54.86M) | 28.38M | (10.95M) | 28.07M | (15.62M) |
| Debt Repayment | 1.02M | (6.49M) | 25.06M | (4.86M) | (2.02M) |
| Common Stock Issued | 97.37M | 0 | 91.78M | 152.08K | 0 |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (1.19M) | (292K) | (602K) | (1.87M) | (1.81M) |
| Financing Cash Flow | 97.2M | (6.78M) | 116.24M | (6.58M) | (3.82M) |
| Effect of Forex Changes | 561K | 254K | 100K | (257K) | 15.87M |
| Net Change in Cash | 39.87M | (21.37M) | 48.73M | (30.59M) | (37.12M) |
| Free Cash Flow | (4.15M) | (44.49M) | (56.85M) | (51.99M) | (33.73M) |
Free Cash Flow
Net Income to FCF bridge
FY2025
= Net Income-$35.6M
+ D&A$1.4M
+ Stock-Based Comp$0
+ Deferred Tax$0
- Working Capital-$2.3M
+ Other Non-Cash$3.0M
= Operating Cash Flow-$33.5M
- Capex-$187.5K
= Free Cash Flow-$33.7M
Analysis
FY2025 free cash flow is -$33.7M. FCF conversion is 94.7% of net income. Operating cash flow was -$33.5M, with capex of -$187.5K. The largest bridge item is Other Non-Cash at $3.0M.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 6-K | 6-K filing | Oct 28, 2026 | |
| 6-K | 6-K filing | Oct 15, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 1, 2026 | |
| 6-K | 6-K filing | Sep 30, 2026 | |
| 6-K | 6-K filing | Sep 30, 2026 |
Does ANL generate free cash flow?
Adlai Nortye Ltd. (ANL) generated -$33.73M of free cash flow in fiscal 2025.
How much operating cash flow does ANL produce?
Operating cash flow was -$33.54M, before capital expenditures of $187,491.00.
Continue the stock analysis
Jump to another research area for this company.